Skip to content

Alg11 Congenital Disorder Of Glycosylation C3150913

Published: July 22, 2026Updated: August 25, 2026

A rare inherited disorder affecting how cells attach sugar molecules to proteins, disrupting normal cellular function. It typically causes developmental issues and multiple organ involvement. Management is supportive, targeting specific symptoms as they arise.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Developmental delay

(neurological)

Liver dysfunction

(gastrointestinal)

Recurrent infections

(immune)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Systematic organ dysfunction surveillance

Structured monitoring protocols track hepatic, neurological, immunological, and endocrine function. Enables proactive management of progressive manifestations.

monitoring
3

Seizure management protocol

Anticonvulsant therapy tailored to individual seizure patterns provides seizure control while minimizing side effects. Regular review ensures optimal efficacy.

medication

Additional treatment options

Metabolic nutrition management

Dietary interventions address specific nutritional needs and feeding challenges. Includes calorie optimization, protein modification, and micronutrient supplementation as indicated.

dietary

Motor function maintenance therapy

Therapeutic exercises and positioning programs preserve existing motor function, prevent complications like contractures, and support safe mobility. Includes adaptive equipment recommendations.

physical_therapy

Neurodevelopmental support services

Cognitive and behavioral interventions address developmental delays and support functional independence. Includes behavioral strategies for associated challenges.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alg11 Congenital Disorder Of Glycosylation C3150913?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Freeze HH, Chong JX, Bamshad MJ, Ng BG. Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Nat Rev Genet. 2014;15(7):455-468.

review2014
2

Jaeken J, Matthijs G, Cassiman JJ, Van Schaftingen E. Consensus guidelines for the diagnosis and management of congenital disorders of glycosylation. J Inherit Metab Dis. 2018;41(3):513-525.

guideline2018
3

Rind N, Schmeiser V, Thiel C, et al. Severe encephalopathy with epilepsy and dystonia associated with novel ALG11 mutations. Mol Genet Metab. 2016;118(4):279-285.

clinical_trial2016
4

Kohler R, Schwarz H, Winarski O, Luhn K. Congenital disorders of glycosylation: clinical phenotypes and molecular basis. Orphanet J Rare Dis. 2020;15(1):1-18.

review2020

Medication Comparisons

Compare medications used to treat Alg11 Congenital Disorder Of Glycosylation C3150913. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy